LONDON, August 10, 2017 /PRNewswire/ --
The top 50 generic drug producers had combined revenues of $92bn in 2016. The top 10 generic drug producers have 62% share of the total revenue made by these top 50 companies. 30% of the top 50 generic drug producers fall under the RoW region. This figure reflects the increasing penetration of generics on a global scale with many pharmaceutical companies realising this industry as a primary source of revenue.
(Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )
How this report will benefit you:
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 214-page report you will receive 74 tables and 71 figures - all unavailable elsewhere.
The 214-page report provides clear detailed insight into the top 50 generic drug producers. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
Report Scope
This report ranks the world's top 50 generic drug manufacturers according to their generic drug revenues in 2016.
Our report assesses the leading generic drug manufacturers worldwide. In general a company profile gives you the following information:
Discussion of activities, technologies and recent financial results
Assessment of developments - mergers and acquisitions (M&A), new products, outlooks, challenges and plans
Historical revenue ($) and CAGR (%) of top players
Forecasting of generic drug revenues to 2027 (for 18 leading companies).
This report discusses the factors that affect the industry:
M&A activity and related partnerships
Global and regional strategies - extending business reach
Competition from companies based in emerging national markets
Increasing specialisation by leading players, including big pharma companies
Increasing consolidation of the generics industry
Advances in production technologies, including difficult-to-make generics and biosimilars - important shifts and opportunities in the industry.
Pharma Leader Series: Top Generic Drug Producers Market Forecast 2017-2027
This report analyses the leading generic drug manufacturers in North America, including these companies:
Mylan
Pfizer
Abbott
Endo Pharmaceuticals
Valeant
This report analyses the leading generic drug manufacturers in Europe, including these companies:
Novartis (Sandoz)
Sanofi
Fresenius Kabi
Pharmstandard
Gedeon Richter
Stada Arzneimittel.
Perrigo
This report analyses the leading generic drug manufacturers in India, including these companies:
Sun Pharmaceutical Industries
Dr. Reddy's Laboratories
Lupin
Cipla
Aurobindo
Glenmark
Torrent Pharma
This report analyses the leading generic drug manufacturers in RoW, including these companies:
Teva Pharmaceutical Industries
EMS
Aspen Pharmacare
Nichi-Iko
Sawai Pharmaceutical
Taro Pharmaceutical
Abdi Ibrahim
Visiongain's study is intended for anyone requiring commercial analyses for the top generic drug manufacturers. You find data, trends and predictions.
Buy our report today Pharma Leader Series: Top Generic Drug Producers Market Forecast 2017-2027: North America, Europe, India, Japan, South Africa, MENA.
To request a report overview of this report please email Sara Peerun at [email protected] or call Tel: +44-(0)-20-7336-6100
Or click on https://www.visiongain.com/Report/1949/Pharma-Leader-Series-Top-Generic-Drug-Producers-Market-Forecast-2017-2027
List of Companies and Organizations Mentioned in the Report
AbbVie
Abdi Ibrahim
Abrika Pharmaceuticals
Ache
Actavis
Active Pharma
Adcock Ingram
Advanced Vision Research
Aegera
Afrexa Life Sciences
Agouron Pharmaceuticals
Akorn Pharmaceuticals
Akrikhin
Alcon
Allergan
Alpharma
Alvogen
AmerisourceBergen
Amide
Amneal Pharmaceuticals
AMS
APL Holdings Limited
ApoPharma
Apotex
Apotex Fermentation
APP Pharmaceuticals
Aprogen
Arrow Group
Asahi Kasei Pharma Corporation
Ascent Pharmahealth
ASKA Pharmaceutical
Aspen
Aspen Pharmacare
Aspen Trading
AstraZeneca
Auden McKenzie
Aurigene Discovery Technologies
Auro Pharma
Aurobindo
Balkanpharma
Barr Pharmaceuticals
Bausch and Lomb Holdings
Bayer
Bayer Yakuhin
BeiKang Pharmaceutical
Bever
Biocad Holding
Bioniche Pharma
Biovena
Boca Pharmacal
Boehringer Ingelheim
Brainfarma Industria e Farmaceutica
Bremer Pharma
Bunker and Delta
Cadila Healthcare
Cardinal Health
Cenova Pharma
CFR Pharmaceuticals
Chattem Chemicals
Chemo Group
Chimpharm
Chiron Corporation
Chirotech Technology
CIBA VISION
Cipla
CNS Therapeutics
Colotech
Cosmed Industria de Cosmeticos e Medicamentos S.A.
D. Searle & Company
Dabur Pharma
DACA Pharmaceuticals
Daichi Kasei
Dialfor Health
DKSH
Dr. Reddy's Laboratories
Dream Pharma
Dusa Pharmaceuticals
EBEWE Pharma
Elan Pharmaceuticals
Elder Pharmaceuticals
Emcure
Emergent Biosolutions
Emploi Quebec
EMS
Endo
Eon Labs
Ethics Bio Lab
Eurofarma
European Medicines Agency (EMA)
Facet Biotech
Fako
Fenwal
Filaxis
Fougera Pharmaceuticals
Fresenius Kabi
Fuso Pharmaceutical Industries
Gangene Corp
Gedeon Richter
Generic Health
Generic Pharmaceutical Association (GPhA)
Genfar S.A.
Genzyme
Germa Pharm
GlaxoSmithKline (GSK)
Glenmark
Globalpharma
Golden Cross Pharma
Greenstone
Handok
HealthTronics
Helvepharm
Herbapol Pruszkow
Hexa
Hikma
Hi-Tech Pharmacal
Hospira
Hypermarcas
IDEV Technologies
Ikaria
Impax Laboratories
Innopharma
Inspire Pharmaceuticals
Investissement Quebec
Ipca Laboratories
J-DOLPH Pharmaceutical
Johnson & Johnson
JPH Group Holdings
Kanghong Sagen Pharmaceuticals
Keri Pharma
Kilitch Drugs
Kolmar Holdings
Krka
Kunwha Pharmaceuticals
Kyowa Pharmaceuticals
Labesfal
Laboratorio Sanderson
Laboratorios Gautier
Laboratorios Grin
Laboratorios Kendrick
Labormed Pharma
Leek
Lekko
Les Laboratoires Servier SAS
Lotus Pharmaceuticals
Lupin
mAbxience
Madaus
Mallinckrodt
Maruko Pharmaceutical
Masterlek
McKesson Drug Company
Mechnikov Biomed
Mediate Specialities
Medina
Medisa Shinyaku
Medley Industria Farmaceutica
Meiji Seika Pharma
Merck & Co
Microdose
Mitani Sangyo
Mitsubishi Tanabe Pharma
MJ Pharma
Multicare
Mylan Laboratories
Nanomi B.V
National Druggists
NBZ Pharma Limited
Negma
Nichi-Iko
Nichi-Iko Pharma Tech
Nicox
Nippon Chemipher
Nippon Kayaku
NIXS Corporation
Novartis
Nycomed
Oak Pharmaceuticals
OctoPlus
Omega Laboratories Limited
Onset Dermatologics
Onyx
Oriel Therapeutics
Orion
Paladin Labs
Par Pharmaceutical
Parke-Davis
Pendopharm
Perrigo Company
Pfizer
PGT Healthcare
Pharma Avalanche
Pharmacin
Pharmapark
Pharmascience
Pharmascience Korea
PharmaSwiss
Pharmstandard
Pharmstandard Biotec
Phlox Pharma
Pinewood Laboratories
Piramal Healthcare Solutions
Polfa Warszawa
Polpharma
Pradeep Drug Company
Promius Pharma
Pymepharco
Qalitest
Questcor
Ranbaxy Laboratories
Ranbaxy Life Sciences Research
Ratiopharm
Ribbon
Richter-Helm
Roche
Romark Laboratories
Sabex
Sagent Acquisition Corp
Salix Pharmaceuticals
Sandoz
Sanofi
Sanofi Pasteur
Sawai Pharmaceuticals
Schein Pharmaceutical
Sekisui Medical
Shantha Biotechnics
Silom Medical Company
Sindan
Solus Pharmaceuticals
Solvay Pharmaceuticals
Somar
Specifar Pharmaceuticals S.A.
SPIL de Mexico
Spirig Pharma
Stada Arzneimittel
STARLIMS
Sun Pharmaceutical
Swisse Wellness
Taiyo Cephalon
Taro
Technologies Inc
Teikoku Medix
Terapia S.A.
Teva Pharmaceutical Industries
The European Generic Medicines Association (EGA)
TKS Pharmaceutical
Torrent Pharmaceuticals
Towa
UDL Laboratories
United Research Laboratories
URL Pharma
US Food and Drug Administration (FDA)
Uteron Pharma S.A.
Valeant
Velefarm
Veropharm
VersaPharm Incorporated
Vindexpharm
VPI Holdings Corp
Warner Chilcott
Warner Lambert
Watson Pharmaceuticals
Winthrop
Wockhardt
Wyeth
World Health Organisation (WHO)
Yakuhan Pharmaceuticals
ZAO Ranbaxy
Zao Sun Pharma
Zhejiang Chiral Medicine Chemicals Company
ZiO Zdorovje
Zoetis
Zydus Pharmaceuticals
Zydus Wellness
To see a report overview please email Sara Peerun on [email protected]
SOURCE Visiongain Ltd
Advertisement
North America, Europe, India, Japan, South Africa, MENA
Advertisement
The top 50 generic drug producers had combined revenues of $92bn in 2016. The top 10 generic drug producers have 62% share of the total revenue made by these top 50 companies. 30% of the top 50 generic drug producers fall under the RoW region. This figure reflects the increasing penetration of generics on a global scale with many pharmaceutical companies realising this industry as a primary source of revenue.
(Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )
How this report will benefit you:
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 214-page report you will receive 74 tables and 71 figures - all unavailable elsewhere.
The 214-page report provides clear detailed insight into the top 50 generic drug producers. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
Report Scope
This report ranks the world's top 50 generic drug manufacturers according to their generic drug revenues in 2016.
Our report assesses the leading generic drug manufacturers worldwide. In general a company profile gives you the following information:
Discussion of activities, technologies and recent financial results
Assessment of developments - mergers and acquisitions (M&A), new products, outlooks, challenges and plans
Historical revenue ($) and CAGR (%) of top players
Forecasting of generic drug revenues to 2027 (for 18 leading companies).
This report discusses the factors that affect the industry:
M&A activity and related partnerships
Global and regional strategies - extending business reach
Competition from companies based in emerging national markets
Increasing specialisation by leading players, including big pharma companies
Increasing consolidation of the generics industry
Advances in production technologies, including difficult-to-make generics and biosimilars - important shifts and opportunities in the industry.
Pharma Leader Series: Top Generic Drug Producers Market Forecast 2017-2027
This report analyses the leading generic drug manufacturers in North America, including these companies:
Mylan
Pfizer
Abbott
Endo Pharmaceuticals
Valeant
This report analyses the leading generic drug manufacturers in Europe, including these companies:
Novartis (Sandoz)
Sanofi
Fresenius Kabi
Pharmstandard
Gedeon Richter
Stada Arzneimittel.
Perrigo
This report analyses the leading generic drug manufacturers in India, including these companies:
Sun Pharmaceutical Industries
Dr. Reddy's Laboratories
Lupin
Cipla
Aurobindo
Glenmark
Torrent Pharma
This report analyses the leading generic drug manufacturers in RoW, including these companies:
Teva Pharmaceutical Industries
EMS
Aspen Pharmacare
Nichi-Iko
Sawai Pharmaceutical
Taro Pharmaceutical
Abdi Ibrahim
Visiongain's study is intended for anyone requiring commercial analyses for the top generic drug manufacturers. You find data, trends and predictions.
Buy our report today Pharma Leader Series: Top Generic Drug Producers Market Forecast 2017-2027: North America, Europe, India, Japan, South Africa, MENA.
To request a report overview of this report please email Sara Peerun at [email protected] or call Tel: +44-(0)-20-7336-6100
Or click on https://www.visiongain.com/Report/1949/Pharma-Leader-Series-Top-Generic-Drug-Producers-Market-Forecast-2017-2027
List of Companies and Organizations Mentioned in the Report
AbbVie
Abdi Ibrahim
Abrika Pharmaceuticals
Ache
Actavis
Active Pharma
Adcock Ingram
Advanced Vision Research
Aegera
Afrexa Life Sciences
Agouron Pharmaceuticals
Akorn Pharmaceuticals
Akrikhin
Alcon
Allergan
Alpharma
Alvogen
AmerisourceBergen
Amide
Amneal Pharmaceuticals
AMS
APL Holdings Limited
ApoPharma
Apotex
Apotex Fermentation
APP Pharmaceuticals
Aprogen
Arrow Group
Asahi Kasei Pharma Corporation
Ascent Pharmahealth
ASKA Pharmaceutical
Aspen
Aspen Pharmacare
Aspen Trading
AstraZeneca
Auden McKenzie
Aurigene Discovery Technologies
Auro Pharma
Aurobindo
Balkanpharma
Barr Pharmaceuticals
Bausch and Lomb Holdings
Bayer
Bayer Yakuhin
BeiKang Pharmaceutical
Bever
Biocad Holding
Bioniche Pharma
Biovena
Boca Pharmacal
Boehringer Ingelheim
Brainfarma Industria e Farmaceutica
Bremer Pharma
Bunker and Delta
Cadila Healthcare
Cardinal Health
Cenova Pharma
CFR Pharmaceuticals
Chattem Chemicals
Chemo Group
Chimpharm
Chiron Corporation
Chirotech Technology
CIBA VISION
Cipla
CNS Therapeutics
Colotech
Cosmed Industria de Cosmeticos e Medicamentos S.A.
D. Searle & Company
Dabur Pharma
DACA Pharmaceuticals
Daichi Kasei
Dialfor Health
DKSH
Dr. Reddy's Laboratories
Dream Pharma
Dusa Pharmaceuticals
EBEWE Pharma
Elan Pharmaceuticals
Elder Pharmaceuticals
Emcure
Emergent Biosolutions
Emploi Quebec
EMS
Endo
Eon Labs
Ethics Bio Lab
Eurofarma
European Medicines Agency (EMA)
Facet Biotech
Fako
Fenwal
Filaxis
Fougera Pharmaceuticals
Fresenius Kabi
Fuso Pharmaceutical Industries
Gangene Corp
Gedeon Richter
Generic Health
Generic Pharmaceutical Association (GPhA)
Genfar S.A.
Genzyme
Germa Pharm
GlaxoSmithKline (GSK)
Glenmark
Globalpharma
Golden Cross Pharma
Greenstone
Handok
HealthTronics
Helvepharm
Herbapol Pruszkow
Hexa
Hikma
Hi-Tech Pharmacal
Hospira
Hypermarcas
IDEV Technologies
Ikaria
Impax Laboratories
Innopharma
Inspire Pharmaceuticals
Investissement Quebec
Ipca Laboratories
J-DOLPH Pharmaceutical
Johnson & Johnson
JPH Group Holdings
Kanghong Sagen Pharmaceuticals
Keri Pharma
Kilitch Drugs
Kolmar Holdings
Krka
Kunwha Pharmaceuticals
Kyowa Pharmaceuticals
Labesfal
Laboratorio Sanderson
Laboratorios Gautier
Laboratorios Grin
Laboratorios Kendrick
Labormed Pharma
Leek
Lekko
Les Laboratoires Servier SAS
Lotus Pharmaceuticals
Lupin
mAbxience
Madaus
Mallinckrodt
Maruko Pharmaceutical
Masterlek
McKesson Drug Company
Mechnikov Biomed
Mediate Specialities
Medina
Medisa Shinyaku
Medley Industria Farmaceutica
Meiji Seika Pharma
Merck & Co
Microdose
Mitani Sangyo
Mitsubishi Tanabe Pharma
MJ Pharma
Multicare
Mylan Laboratories
Nanomi B.V
National Druggists
NBZ Pharma Limited
Negma
Nichi-Iko
Nichi-Iko Pharma Tech
Nicox
Nippon Chemipher
Nippon Kayaku
NIXS Corporation
Novartis
Nycomed
Oak Pharmaceuticals
OctoPlus
Omega Laboratories Limited
Onset Dermatologics
Onyx
Oriel Therapeutics
Orion
Paladin Labs
Par Pharmaceutical
Parke-Davis
Pendopharm
Perrigo Company
Pfizer
PGT Healthcare
Pharma Avalanche
Pharmacin
Pharmapark
Pharmascience
Pharmascience Korea
PharmaSwiss
Pharmstandard
Pharmstandard Biotec
Phlox Pharma
Pinewood Laboratories
Piramal Healthcare Solutions
Polfa Warszawa
Polpharma
Pradeep Drug Company
Promius Pharma
Pymepharco
Qalitest
Questcor
Ranbaxy Laboratories
Ranbaxy Life Sciences Research
Ratiopharm
Ribbon
Richter-Helm
Roche
Romark Laboratories
Sabex
Sagent Acquisition Corp
Salix Pharmaceuticals
Sandoz
Sanofi
Sanofi Pasteur
Sawai Pharmaceuticals
Schein Pharmaceutical
Sekisui Medical
Shantha Biotechnics
Silom Medical Company
Sindan
Solus Pharmaceuticals
Solvay Pharmaceuticals
Somar
Specifar Pharmaceuticals S.A.
SPIL de Mexico
Spirig Pharma
Stada Arzneimittel
STARLIMS
Sun Pharmaceutical
Swisse Wellness
Taiyo Cephalon
Taro
Technologies Inc
Teikoku Medix
Terapia S.A.
Teva Pharmaceutical Industries
The European Generic Medicines Association (EGA)
TKS Pharmaceutical
Torrent Pharmaceuticals
Towa
UDL Laboratories
United Research Laboratories
URL Pharma
US Food and Drug Administration (FDA)
Uteron Pharma S.A.
Valeant
Velefarm
Veropharm
VersaPharm Incorporated
Vindexpharm
VPI Holdings Corp
Warner Chilcott
Warner Lambert
Watson Pharmaceuticals
Winthrop
Wockhardt
Wyeth
World Health Organisation (WHO)
Yakuhan Pharmaceuticals
ZAO Ranbaxy
Zao Sun Pharma
Zhejiang Chiral Medicine Chemicals Company
ZiO Zdorovje
Zoetis
Zydus Pharmaceuticals
Zydus Wellness
To see a report overview please email Sara Peerun on [email protected]
SOURCE Visiongain Ltd
